Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria vaccine.

U Certa1

  • 1Central Research Unit, Hoffmann-La Roche Ltd., Basel, Switzerland.

Experientia
|February 15, 1991
PubMed
Summary

Developing a malaria vaccine is challenging due to Plasmodium falciparum's polymorphic antigens. Research focuses on surface proteins, but new molecules are needed for effective malaria prevention in children and adults.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A porcine model of osteosarcoma.

Oncogenesis·2016
Same author

Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA.

Nature nanotechnology·2008
Same author

Antiproliferative activity of the human IFN-alpha-inducible protein IFI44.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·2007
Same author

Interferon-alpha and transforming growth factor-beta co-induce growth inhibition of human tumor cells.

Cellular and molecular life sciences : CMLS·2006
Same author

Reversible inactivation of the dorsal hippocampus by tetrodotoxin or lidocaine: a comparative study on cerebral functional activity and motor coordination in the rat.

Neuroscience·2006
Same author

Improved biological and transcriptional activity of monopegylated interferon-alpha-2a isomers.

The pharmacogenomics journal·2003

Area of Science:

  • Immunology
  • Parasitology
  • Vaccinology

Background:

  • Malaria remains a leading cause of childhood mortality globally.
  • Adults in endemic areas develop partial immunity to Plasmodium falciparum, suggesting vaccine potential.
  • Parasite polymorphism complicates vaccine development by limiting antigen targets.

Purpose of the Study:

  • To explore the feasibility of a malaria vaccine by analyzing Plasmodium falciparum antigens.
  • To identify promising vaccine candidate antigens for malaria prevention.
  • To highlight the urgent need for novel vaccine strategies due to drug resistance.

Main Methods:

  • Utilized human immune sera to identify and clone candidate antigens.
  • Performed genetic and biochemical analysis of Plasmodium falciparum parasite proteins.
  • Evaluated immune responses against major surface proteins of parasite stages.

Main Results:

  • Identified polymorphic antigens, many specific to parasite isolates, hindering vaccine development.
  • Major surface proteins of sporozoites and blood-stage parasites emerged as promising candidates.
  • Current immune responses against these antigens are insufficient for complete protection.

Conclusions:

  • Vaccination against malaria is a viable goal, supported by natural immunity observations.
  • Further research is critical to discover new molecules for a comprehensive malaria vaccine cocktail.
  • The increasing drug and vector resistance necessitates accelerated vaccine development efforts.

Related Experiment Videos